Pete Zorn

Pete Zorn served most recently as Chief Corporate Officer and General Counsel at Albireo Pharma where he led the corporate development, legal, corporate communications, and human resource functions. While at Albireo, Mr. Zorn successfully negotiated and executed the strategic share exchange that resulted in Albireo going public, as well as several other value-creating transactions. Previously, he was General Counsel and Vice President of Communications at Santaris Pharma, an RNA therapeutics company acquired by Roche, and Senior Vice President and General Counsel at Targacept, where he was instrumental in a variety of significant milestones, including its company-launching spinout, IPO, additional financings, business operations achievements, and multiple complex collaborations with major pharmaceutical companies. Mr. Zorn began his career at a large law firm in North Carolina and received his A.B with honors from Harvard College and his J.D. with honors from the University of North Carolina at Chapel Hill.